EE200000513A - Erinevaid heterotsükliliste tuumade süsteeme sisaldavate 5-lipoksügenaasi inhibiitorite valmistamise protsess - Google Patents

Erinevaid heterotsükliliste tuumade süsteeme sisaldavate 5-lipoksügenaasi inhibiitorite valmistamise protsess

Info

Publication number: EE200000513A
Authority: EE; Estonia
Prior art keywords: preparation; heterocyclic ring; ring systems; containing different; lipoxygenase inhibitors
Prior art date: 1999-08-31

Application number

EEP200000513A

Other languages

English (en)

Inventor

Norris Timothy

Elizabeth Hnatow Megan

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-31

Filing date

2000-08-31

Publication date

2001-04-16

2000-08-31 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2001-04-16 Publication of EE200000513A publication Critical patent/EE200000513A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Pyridine Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Catalysts (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

EEP200000513A 1999-08-31 2000-08-31 Erinevaid heterotsükliliste tuumade süsteeme sisaldavate 5-lipoksügenaasi inhibiitorite valmistamise protsess EE200000513A (et)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US15161099P	1999-08-31	1999-08-31

Publications (1)

Publication Number	Publication Date
EE200000513A true EE200000513A (et)	2001-04-16

Family

ID=22539510

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200000513A EE200000513A (et)	1999-08-31	2000-08-31	Erinevaid heterotsükliliste tuumade süsteeme sisaldavate 5-lipoksügenaasi inhibiitorite valmistamise protsess

Country Status (33)

Country	Link
EP (1)	EP1081144A3 (et)
JP (1)	JP2001106686A (et)
KR (1)	KR20010050274A (et)
CN (1)	CN1286251A (et)
AP (1)	AP2000001909A0 (et)
AR (1)	AR022650A1 (et)
AU (1)	AU5370200A (et)
BG (1)	BG104730A (et)
BR (1)	BR0003888A (et)
CA (1)	CA2316748A1 (et)
CO (1)	CO5180623A1 (et)
CZ (1)	CZ20003159A3 (et)
EA (1)	EA200000803A3 (et)
EE (1)	EE200000513A (et)
GT (1)	GT200000144A (et)
HR (1)	HRP20000565A2 (et)
HU (1)	HUP0003437A3 (et)
ID (1)	ID27128A (et)
IL (1)	IL138089A0 (et)
IS (1)	IS5604A (et)
MA (1)	MA26750A1 (et)
NO (1)	NO20004312L (et)
NZ (1)	NZ506633A (et)
OA (1)	OA11451A (et)
PA (1)	PA8499601A1 (et)
PE (1)	PE20010523A1 (et)
PL (1)	PL342280A1 (et)
SG (1)	SG87145A1 (et)
SK (1)	SK12862000A3 (et)
SV (1)	SV2002000160A (et)
TN (1)	TNSN00176A1 (et)
TR (1)	TR200002530A2 (et)
UY (1)	UY26315A1 (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1627644A4 (en) *	2003-05-23	2012-01-18	Hisamitsu Pharmaceutical Co	PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION WITH AN NON-TEROIDAL INFLAMMATORY MEDICAMENT AND AN INTERLEUKIN 1A PRODUCTION INHIBITOR
US7674811B2 (en)	2006-03-14	2010-03-09	Ranbaxy Laboratories Limited	5-lipoxygenase inhibitors
CN103980312B (zh) *	2014-05-27	2016-09-07	广州大学	一种n杂环双膦配体及其合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK281577B6 (sk) *	1994-10-18	2001-05-10	Pfizer Inc.	Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze

2000
- 2000-08-01 SG SG200004340A patent/SG87145A1/en unknown
- 2000-08-10 PA PA20008499601A patent/PA8499601A1/es unknown
- 2000-08-11 CO CO00060138A patent/CO5180623A1/es not_active Application Discontinuation
- 2000-08-17 EP EP00307046A patent/EP1081144A3/en not_active Withdrawn
- 2000-08-18 OA OA1200000224A patent/OA11451A/en unknown
- 2000-08-24 TN TNTNSN00176A patent/TNSN00176A1/fr unknown
- 2000-08-24 IL IL13808900A patent/IL138089A0/xx unknown
- 2000-08-25 IS IS5604A patent/IS5604A/is unknown
- 2000-08-25 SK SK1286-2000A patent/SK12862000A3/sk unknown
- 2000-08-28 ID IDP20000710A patent/ID27128A/id unknown
- 2000-08-28 UY UY26315A patent/UY26315A1/es not_active Application Discontinuation
- 2000-08-29 BG BG104730A patent/BG104730A/xx unknown
- 2000-08-29 PE PE2000000886A patent/PE20010523A1/es not_active Application Discontinuation
- 2000-08-29 GT GT200000144A patent/GT200000144A/es unknown
- 2000-08-29 AU AU53702/00A patent/AU5370200A/en not_active Abandoned
- 2000-08-29 CA CA002316748A patent/CA2316748A1/en not_active Abandoned
- 2000-08-29 AR ARP000104489A patent/AR022650A1/es not_active Application Discontinuation
- 2000-08-30 KR KR1020000050877A patent/KR20010050274A/ko active IP Right Grant
- 2000-08-30 NO NO20004312A patent/NO20004312L/no not_active Application Discontinuation
- 2000-08-30 CN CN00126409A patent/CN1286251A/zh active Pending
- 2000-08-30 CZ CZ20003159A patent/CZ20003159A3/cs unknown
- 2000-08-30 NZ NZ506633A patent/NZ506633A/en unknown
- 2000-08-30 MA MA26053A patent/MA26750A1/fr unknown
- 2000-08-30 BR BR0003888-1A patent/BR0003888A/pt not_active IP Right Cessation
- 2000-08-30 HU HU0003437A patent/HUP0003437A3/hu unknown
- 2000-08-30 HR HR20000565A patent/HRP20000565A2/hr not_active Application Discontinuation
- 2000-08-30 SV SV2000000160A patent/SV2002000160A/es unknown
- 2000-08-31 PL PL00342280A patent/PL342280A1/xx not_active Application Discontinuation
- 2000-08-31 EE EEP200000513A patent/EE200000513A/et unknown
- 2000-08-31 JP JP2000262200A patent/JP2001106686A/ja active Pending
- 2000-08-31 AP APAP/P/2000/001909A patent/AP2000001909A0/en unknown
- 2000-08-31 EA EA200000803A patent/EA200000803A3/ru unknown
- 2000-08-31 TR TR2000/02530A patent/TR200002530A2/xx unknown

Also Published As

Publication number	Publication date
IS5604A (is)	2001-03-01
NO20004312L (no)	2001-03-01
CO5180623A1 (es)	2002-07-30
NZ506633A (en)	2001-12-21
PL342280A1 (en)	2001-03-12
CZ20003159A3 (cs)	2001-12-12
PE20010523A1 (es)	2001-04-28
AU5370200A (en)	2001-03-08
OA11451A (en)	2003-12-08
HUP0003437A3 (en)	2002-08-28
TR200002530A2 (tr)	2001-04-20
EA200000803A3 (ru)	2001-06-25
EP1081144A2 (en)	2001-03-07
CN1286251A (zh)	2001-03-07
ID27128A (id)	2001-03-01
BG104730A (en)	2001-09-28
SK12862000A3 (sk)	2002-02-05
EA200000803A2 (ru)	2001-04-23
HU0003437D0 (en)	2000-08-30
PA8499601A1 (es)	2002-02-21
IL138089A0 (en)	2001-10-31
GT200000144A (es)	2002-02-20
CA2316748A1 (en)	2001-02-28
MA26750A1 (fr)	2004-12-20
SG87145A1 (en)	2002-03-19
TNSN00176A1 (fr)	2005-11-10
AR022650A1 (es)	2002-09-04
AP2000001909A0 (en)	2000-09-30
NO20004312D0 (no)	2000-08-30
JP2001106686A (ja)	2001-04-17
SV2002000160A (es)	2002-01-23
EP1081144A3 (en)	2001-04-11
BR0003888A (pt)	2001-12-11
HRP20000565A2 (en)	2001-06-30
KR20010050274A (ko)	2001-06-15
HUP0003437A2 (hu)	2001-06-28
UY26315A1 (es)	2001-04-30

Publication	Publication Date	Title
NO20025186L (no)	2003-01-14	Fremgangsmåte for syntese av en ecteinascidinforbindelse
IS5982A (is)	2001-06-28	Aðferð til framleiðslu á 5-sýanóþalíði
NO20022125D0 (no)	2002-05-03	Pyrrolderivater som inhibitorer for fosfodiesterase VII
NO20013569D0 (no)	2001-07-19	Fremgangsmåte ved fremstilling av L-fenylephrine-hydroklorid
NO20022123D0 (no)	2002-05-03	Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
FI990509A (fi)	2000-09-10	Häiriönpoistomenetelmä
EE200000513A (et)	2001-04-16	Erinevaid heterotsükliliste tuumade süsteeme sisaldavate 5-lipoksügenaasi inhibiitorite valmistamise protsess
NO20020059L (no)	2002-03-04	Fremgangsmåte for fremstilling av dibenzotiazepinderivater
EE200000512A (et)	2001-04-16	Erinevaid heterotsükliliste tuumade süsteeme sisaldavate 5-lipoksügenaasi inhibiitorite valmistamise protsess
NO20013407L (no)	2001-07-10	Fremgangsmate for fremstilling av kinolinkarbaldehyd
NO20013995L (no)	2001-10-17	Fremgangsmåte for fremstilling av L-sorbose
NO20024887D0 (no)	2002-10-10	Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20014383L (no)	2001-11-02	Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
DE60000817D1 (de)	2003-01-02	Calixaren-derivate für extraktion von aktiniden
NO20022956L (no)	2002-06-19	Fremgangsmate for fremstilling av nitroguanidin
NO20000805D0 (no)	2000-02-18	Fremgangsmåte for fremstilling av organiske azider
NO20001985L (no)	2000-10-16	FremgangsmÕte for forming av strimmelformede folier
HU0003438D0 (en)	2000-08-30	Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20021788D0 (no)	2002-04-16	Fremgangsmåte for fremstilling av ulcerterapeutika
NO20022671D0 (no)	2002-06-06	Fremgangsmåte for fremstilling av tienopyrimidiner
NO20002558D0 (no)	2000-05-18	FremgangsmÕte for fremstilling av findisperse eksplosivstoffer
NO20014451D0 (no)	2001-09-13	Fremgangsmåte for fremstilling av tiazolidinderivater
GB9906120D0 (en)	1999-05-12	Process for the preparation of new heterocyclic compounds